Half Year 2023 Neuren Pharmaceuticals Ltd Earnings Call TranscriptAug 28, 2023A$12.69 (+1.52%)Earnings- Neuren Pharmaceuticals Ltd at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Neuren Pharmaceuticals Ltd at MST Access Australian Micro & Small Caps Conference (Virtual) TranscriptJun 15, 2021
Neuren Pharmaceuticals Ltd at MST Access Australian Micro & Small Caps Conference (Virtual) Transcript
Good morning, everyone, welcome to the MSC Access Micro Cap and Small Caps Conference. Today we're lucky enough to have Jon Pilcher who is the CEO of Neuren to present. Neuren is $150 million market cap company, and it's one of the great Australian [feel good] microcap stories on the [A6].
We certainly see Neuren as calendar year '21, calendar year '22, transformational years for the company. They're in a net cash position of about $22 million on the balance sheet. And it's a great opportunity to catch up with Neuren and to see what Jon thinks are the upcoming key moments for the company.
John's going to give a 20-minute presentation. And then after that, we'll have a short 5- to 10-minute Q&A session afterwards. (Conference Instructions) Welcome, John, and thanks for taking the time to present. I'll hand over to you.
Thank you, Jamie, and good morning, everyone. Thanks very much for your time this morning. So Neuren's developing two drugs to treat six different
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
